GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » 5-Year Yield-on-Cost %

Cabio Biotech (Wuhan) Co (SHSE:688089) 5-Year Yield-on-Cost % : 2.03 (As of Jun. 04, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co 5-Year Yield-on-Cost %?

Cabio Biotech (Wuhan) Co's yield on cost for the quarter that ended in Mar. 2024 was 2.03.


The historical rank and industry rank for Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:688089' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.49   Med: 1.04   Max: 2.54
Current: 2.03


During the past 11 years, Cabio Biotech (Wuhan) Co's highest Yield on Cost was 2.54. The lowest was 0.49. And the median was 1.04.


SHSE:688089's 5-Year Yield-on-Cost % is ranked better than
52.23% of 157 companies
in the Biotechnology industry
Industry Median: 1.78 vs SHSE:688089: 2.03

Competitive Comparison of Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost % falls into.



Cabio Biotech (Wuhan) Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Cabio Biotech (Wuhan) Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Cabio Biotech (Wuhan) Co  (SHSE:688089) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Cabio Biotech (Wuhan) Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Xiao Min senior management
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines